Microengineered bioartificial liver chip for drug toxicity screening
Date
2018
Authors
Delalat, B.
Cozzi, C.
Rasi Ghaemi, S.
Polito, G.
Kriel, F.H.
Michl, T.D.
Harding, F.J.
Priest, C.
Barillaro, G.
Voelcker, N.H.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Advanced Functional Materials, 2018; 28(28, article no. 1801825):1-10
Statement of Responsibility
Conference Name
Abstract
Microfluidic 3D cell culture is a promising technology for the screening of drug toxicity profiles. In this study, a bioartificial liver consisting of a surface‐engineered microfluidic silicon chip with microtrenches mimicking hepatic sinusoids is shown to extend 3D primary hepatocyte culture and improve in vitro drug screening for hepatotoxicity, with respect to the state‐of‐the‐art literature on this subject. Primary hepatocytes hosted in the 3D heparin‐coated microtrenches (the bioartificial liver) secrete high levels of albumin and urea over 4 weeks. The cytotoxicity of common drugs, namely, acetaminophen, chlorpromazine, and tacrine, was assessed on primary hepatocytes both at day 1 and day 7. The results suggest that mimicking hepatic sinusoids using a microtrench format allows the maintenance of difficult‐to‐culture primary hepatocytes to be extended to 4 weeks and provides an alternative model to animal studies for the screening of the cytotoxicity of new drugs.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2018 WILEY-VCH Verlag